Repurposed cancer drug rapidly eased rare autoimmune neuropathy in two patients

Дата публикации: 06-07-2026 15:00:06

An interdisciplinary team at Jena University Hospital achieved a surprisingly rapid and significant improvement in two patients with an autoimmune peripheral nervous system disorder. The team administered teclistamab, a drug originally developed for multiple myeloma, and reported in detail in Nature Communications.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Scientists “recharge” damaged nerves to ease chronic pain	0	6.9	24-05-2026
2	Sclerosi multipla, la svolta arriva da un farmaco già esistente: può riparare il sistema nervoso	0	4.28	22-01-2026
3	New, improved method to find and isolate the strongest cancer-fighting immune cells	7	8	08-07-2026
4	Brain tumor vaccine links mutation targeting to eight-year survival gains	7	8	06-07-2026
5	Dallas clinical trial testing new approach to ALS gives patients & doctors hope	0	11.88	31-07-2026
6	FDA accepts cemdisiran for priority review as gMG treatment	2	6	07-07-2026
7	Ученые создали новый метод лечения опухолевых заболеваний	0	0	06-09-2019
8	Breakthrough for patients with pancreatic cancer as doctors develop new blood test that can pick up 'residue cells' of the 'silent' disease that killed Alan Rickman	8	7	30-06-2026
9	First patient receives neural stem cell therapy in groundbreaking UCI Health Huntington's disease clinical trial	7	8	23-06-2026
10	В РФ готовится к испытаниям отечественный препарат для лечения аутоиммунных заболеваний	0	0	16-07-2019

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 7. Информативность: 8. Источник: medicalxpress.com.